Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)
OTCMKTS · Delayed Price · Currency is USD
15.47
-0.38 (-2.40%)
Sep 15, 2025, 9:30 AM EDT
RICFY Market Cap
RICFY has a market cap or net worth of $12.21 billion as of September 26, 2025. Its market cap has increased by 5.73% in one year.
Market Cap
12.21B
Enterprise Value
14.71B
Revenue
2.91B
Ranking
n/a
PE Ratio
25.52
Stock Price
$15.47
Market Cap Chart
Since March 31, 1997, RICFY's market cap has increased from 557.63M to 12.21B, an increase of 2,088.93%. That is a compound annual growth rate of 11.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 12.21B | 13.70% |
| Dec 30, 2024 | 10.74B | -3.28% |
| Dec 29, 2023 | 11.10B | 30.48% |
| Dec 30, 2022 | 8.51B | -35.55% |
| Dec 30, 2021 | 13.20B | 15.13% |
| Dec 30, 2020 | 11.46B | 33.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 681.58M |
| Glass House Brands | 518.99M |
| Northwest Biotherapeutics | 377.99M |
| CytoDyn | 345.51M |
| American Oncology Network | 308.52M |
| Nika Pharmaceuticals | 301.74M |